News
Peli BioThermal Showcase Life-Saving Products at DSEI
Peli BioThermal, the global name in temperature controlled packaging solutions, will showcase its latest version of Golden Hour™One products for the first time at DSEI 2021, the world’s largest gathering of the defence and security community.
The Peli BioThermal team...
Drug Research
Recro and BioCorRx expand partnership for OUD treatment
Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, and BioCorRx, Inc., a developer and provider of advanced solutions in the treatment of substance use...
Drug Research
GeneQuine Selects Exothera to Support the Next Stage of Its Osteoarthritis Gene Therapy Development
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to conduct a feasibility study for the development...
News
AirBridgeCargo Airlines completes a series of charter flights with packaging machines for COVID-19 associated items
AirBridgeCargo Airlines, part of Volga-Dnepr Group and one of the leaders in air transportations for the healthcare sector, has accomplished five Boeing 747F charter flights with packaging machines for COVID-19 associated materials from Frankfurt (Germany) to Atlanta (USA).
Over 200...
News
Easyfairs partners with MIND Exhibitions to launch Connect in Pharma
Easyfairs continues to grow in packaging sector in Europe. The events organizer is extending its international network with the creation of a new trade show dedicated to the packaging of pharmaceutical and medical devices in Geneva.
Dubbed Connect in Pharma,...
Drug Research
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential
Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, announced a four-year collaboration with the Bill & Melinda Gates Foundation, a non-profit focused on fighting global poverty, disease, and inequity, to develop small...
Drug Research
NeuExcell and Spark partner to develop gene therapy for Huntingtons Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD).
Under the terms of the agreement, Spark Therapeutics will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.